Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rheumatoid arthritis
rheumatoid arthritis
AbbVie Ups Ante on JAK Inhibitor
Motley Fool
Sat, 06/1/13 - 12:21 pm
AbbVie
rheumatoid arthritis
JAK inhibitors
High doses of common painkillers increase heart attack risks
Reuters
Thu, 05/30/13 - 08:58 am
ibuprofen
diclofenac
rheumatoid arthritis
NSAIDs
COX-2 inhibitors
3 Drug Catalysts to Watch in 2013
Motley Fool
Fri, 05/10/13 - 08:58 am
MannKind
Merck
Pfizer
Sanofi
Rigel Pharmaceuticals
suvorexant
insomnia
diabetes
Afrezza
fostamatinib
rheumatoid arthritis
Enbrel's Asian Biosimilar Competitors
Seeking Alpha
Fri, 04/26/13 - 10:50 am
biosimilars
Enbrel
Amgen
Cipla
Pfizer
Etacept
rheumatoid arthritis
Pfizer’s Arthritis Drug Rejected by European Regulators
Bloomberg
Fri, 04/26/13 - 10:35 am
Pfizer
Europe
rheumatoid arthritis
Xeljanz
AZ arthritis drug may ease symptoms, but not progression
Delaware Online
Sat, 04/6/13 - 11:10 am
AstraZeneca
rheumatoid arthritis
arthritis
fostamatinib
AstraZeneca's Arthritis Drug Succeeds in Phase 3 Trial
Motley Fool
Sat, 04/6/13 - 11:06 am
AstraZeneca
fostamatinib
rheumatoid arthritis
arthritis
AstraZeneca, Rigel arthritis pill disappoints again
Reuters
Fri, 04/5/13 - 10:22 am
Rigel
AstraZeneca
fostamatinib
rheumatoid arthritis
Pfizer says XELJANZ approved in Japan for treatment of adults with RA
Yahoo/Fly on the Wall
Mon, 03/25/13 - 10:59 am
Pfizer
Xeljanz
rheumatoid arthritis
Japan
Taxpayer Funds, A Pfizer Drug And Big Profits
Pharmalot
Tue, 03/19/13 - 10:56 am
Pfizer
JAK3 inhibitors
Xeljanz
rheumatoid arthritis
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Sun, 03/3/13 - 11:32 am
AbbVie
GLPG0634
BT-061
rheumatoid arthritis
psoriasis
Merck's Weakest Blockbuster?
Motley Fool
Tue, 02/19/13 - 09:41 am
Merck
Remicade
rheumatoid arthritis
AbbVie
Humira
Does the Arthritis Market Have Growing Pains?
Motley Fool
Mon, 02/18/13 - 11:53 am
rheumatoid arthritis
TNF blockers
Humira
AbbVie
Pfizer
Xeljanz
Does the Arthritis Market Have Growing Pains?
Motley Fool
Sun, 02/17/13 - 11:51 am
rheumatoid arthritis
AbbVie
Pfizer
Merck
JNJ
Amgen
Is This Pipeline Biologic a Future Blockbuster?
Motley Fool
Sat, 02/16/13 - 12:20 pm
CNTO 136
JNJ
sirukumab
GSK
rheumatoid arthritis
Update on Lilly's Tabalumab
Yahoo/Zacks
Tue, 02/12/13 - 11:12 am
Eli Lilly
tabalumab
rheumatoid arthritis
Can Johnson & Johnson Cash In on Stelara?
Motley Fool
Sat, 02/9/13 - 12:06 pm
JNJ
Stelara
psoriasis
rheumatoid arthritis
Chron's Disease
Lilly stops development of rheumatoid arthritis drug
Reuters
Thu, 02/7/13 - 10:09 am
rheumatoid arthritis
Eli Lilly
tabalumab
How Much? Payers And The New Pfizer RA Pill
Pharmalot
Thu, 01/3/13 - 11:33 am
Pfizer
rheumatoid arthritis
Xeljanz
Horizon Pharma gets UK nod for arthritis drug
Yahoo/AP
Fri, 12/21/12 - 10:40 am
Horizon Pharma
UK
Duexis
osteoarthritis
rheumatoid arthritis
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »